Diabetes Drugs Go Head-to-Head in Study (HealthDay)

[riky]

Diabetes Drugs Go Head-to-Head in Study
    (HealthDay)

 


HealthDay - THURSDAY, Dec. 3 (HealthDay News)  -- A class of drugs still taken by
millions of people with type 2 diabetes is associated with a higher risk
of dying and heart failure than the newer treatment metformin, researchers
say.


You are not allowed to view links. Register or Login/news.yahoo.com/s/hsn/20091205/hl_hsn/diabetesdrugsgoheadtoheadinstudy